stoxline Quote Chart Rank Option Currency Glossary
  
Azitra, Inc. (AZTR)
1.26  0.28 (28.57%)    12-08 15:58
Open: 1.02
High: 1.27
Volume: 28,770
  
Pre. Close: 0.98
Low: 1.02
Market Cap: 15(M)
Technical analysis
2023-12-08 4:41:48 PM
Short term     
Mid term     
Targets 6-month :  1.84 1-year :  2.3
Resists First :  1.58 Second :  1.97
Pivot price 1.17
Supports First :  0.94 Second :  0.79
MAs MA(5) :  1.03 MA(20) :  1.29
MA(100) :  1.95 MA(250) :  0
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  18.2 D(3) :  7.6
RSI RSI(14): 47.8
52-week High :  4.94 Low :  0.94
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AZTR ] has closed below upper band by 38.9%. Bollinger Bands are 8.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.27 - 1.28 1.28 - 1.28
Low: 1.01 - 1.01 1.01 - 1.02
Close: 1.25 - 1.26 1.26 - 1.27
Company Description

Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.

Headline News

Mon, 16 Oct 2023
Azitra to Present at the ThinkEquity Conference - Business Wire

Mon, 14 Aug 2023
Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates - PR Newswire

Wed, 19 Jul 2023
Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors - PR Newswire

Tue, 11 Jul 2023
Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer - PR Newswire

Wed, 21 Jun 2023
Azitra, Inc. Announces Closing of Initial Public Offering - PR Newswire

Tue, 20 Jun 2023
Branford-based Azitra aims to raise $7.5M in IPO - Hartford Business Journal

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
ASE
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android